A. Joseph Sowell's most recent trade in HCA Healthcare Inc was a trade of 13,367 Common Stock done . Disclosure was reported to the exchange on Aug. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 05 Aug 2024 | 13,367 | 18,526 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 05 Aug 2024 | 13,367 | 0 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 15 May 2024 | 19,000 | 0 | - | - | Stock Appreciation Right | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 15 May 2024 | 19,000 | 23,275 (0%) | 0% | 69.0 | 1,310,240 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 15 May 2024 | 9,908 | 13,367 (0%) | 0% | 327.0 | 3,239,520 | Common Stock | |
| HCA Healthcare | A. Joseph Sowell | SVP; Chief Development Officer | 16 Feb 2024 | 6,280 | 6,280 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Sowell Joseph A. | SVP; Chief Development Officer | 16 Feb 2024 | 2,005 | 4,275 (0%) | 0% | 308.6 | 618,643 | Common Stock | |
| HCA Healthcare | Sowell A. Joseph | SVP; Chief Development Officer | 31 Jan 2024 | 4,402 | 4,402 | - | - | Stock Appreciation Right | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 0 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 29,771 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 5,159 | 0 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 10 Nov 2023 | 5,159 | 5,159 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 17 Feb 2023 | 7,600 | 7,600 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 17 Feb 2023 | 2,441 | 5,159 (0%) | 0% | 262.8 | 641,592 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 30 Jan 2023 | 6,315 | 6,315 | - | - | Stock Appreciation Right | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 28 Oct 2022 | 12,946 | 0 (0%) | 0% | 223.2 | 2,889,304 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 27,500 | 0 | - | - | Stock Appreciation Right | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 27,500 | 27,500 (0%) | 0% | 48.0 | 1,319,175 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 17,051 | 33,371 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 17,051 | 0 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 14,554 | 12,946 (0%) | 0% | 214.4 | 3,120,378 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 5,000 | 16,320 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 25 Oct 2022 | 3,600 | 29,771 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 11 Mar 2022 | 11,522 | 17,051 (0%) | 0% | 269 | 3,099,418 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 18 Feb 2022 | 7,740 | 31,619 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 18 Feb 2022 | 3,046 | 28,573 (0%) | 0% | 244.1 | 743,529 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 28 Jan 2022 | 6,930 | 6,930 | - | - | Stock Appreciation Right | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 04 Jan 2022 | 23,375 | 35,732 (0%) | 0% | 48.0 | 1,121,299 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 04 Jan 2022 | 23,375 | 0 | - | - | Stock Appreciation Right | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 04 Jan 2022 | 22,198 | 12,357 (0%) | 0% | 259.2 | 5,754,390 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 04 Jan 2022 | 11,853 | 23,879 (0%) | 0% | 259.0 | 3,069,571 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 29 Dec 2021 | 42,750 | 0 | - | - | Stock Appreciation Right | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 29 Dec 2021 | 42,750 | 55,107 (0%) | 0% | 37.2 | 1,589,445 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 29 Dec 2021 | 20,552 | 34,555 (0%) | 0% | 258.5 | 5,312,486 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 18 Feb 2021 | 10,147 | 15,517 (0%) | 0% | 0 | Common Stock | ||
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 18 Feb 2021 | 3,160 | 12,357 (0%) | 0% | 174.6 | 551,768 | Common Stock | |
| HCA Healthcare | Joseph A. Sowell | SVP; Chief Development Officer | 03 Feb 2021 | 10,460 | 10,460 | - | - | Stock Appreciation Right |